Hepion Pharmaceuticals, Inc. Quarterly Operating Income (Loss) in USD from Q2 2013 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
The net result for the period of deducting operating expenses from operating revenues.
Summary
Hepion Pharmaceuticals, Inc. quarterly/annual Operating Income (Loss) history and growth rate from Q2 2013 to Q3 2024.
  • Hepion Pharmaceuticals, Inc. Operating Income (Loss) for the quarter ending September 30, 2024 was -$4.46M, a 58.2% increase year-over-year.
  • Hepion Pharmaceuticals, Inc. Operating Income (Loss) for the twelve months ending September 30, 2024 was -$28.6M, a 40.3% increase year-over-year.
  • Hepion Pharmaceuticals, Inc. annual Operating Income (Loss) for 2023 was -$48.4M, a 6.51% decline from 2022.
  • Hepion Pharmaceuticals, Inc. annual Operating Income (Loss) for 2022 was -$45.5M, a 49.6% decline from 2021.
  • Hepion Pharmaceuticals, Inc. annual Operating Income (Loss) for 2021 was -$30.4M, a 50.9% decline from 2020.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Quarterly (USD)
Operating Income (Loss), YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 -$28.6M -$4.46M +$6.21M +58.2% Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-14
Q2 2024 -$34.8M -$8.5M +$5.66M +40% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-13
Q1 2024 -$40.4M -$5.18M +$8.03M +60.8% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-21
Q4 2023 -$48.4M -$10.4M -$636K -6.51% Oct 1, 2023 Dec 31, 2023 10-K 2024-04-16
Q3 2023 -$47.8M -$10.7M -$2.2M -26% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-14
Q2 2023 -$45.6M -$14.2M +$5.83M +29.2% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-13
Q1 2023 -$51.4M -$13.2M -$5.96M -82.1% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-21
Q4 2022 -$45.5M -$9.77M -$773K -8.59% Oct 1, 2022 Dec 31, 2022 10-K 2024-04-16
Q3 2022 -$44.7M -$8.47M +$52K +0.61% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-20
Q2 2022 -$44.8M -$20M -$13.1M -192% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-14
Q1 2022 -$31.6M -$7.25M -$1.22M -20.2% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-12
Q4 2021 -$30.4M -$9M -$4.05M -81.7% Oct 1, 2021 Dec 31, 2021 10-K 2023-04-10
Q3 2021 -$26.4M -$8.52M -$2.29M -36.7% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-14
Q2 2021 -$24.1M -$6.85M -$2.08M -43.5% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-15
Q1 2021 -$22M -$6.03M -$1.84M -44.1% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-16
Q4 2020 -$20.1M -$4.95M -$2.71M -121% Oct 1, 2020 Dec 31, 2020 10-K 2022-04-08
Q3 2020 -$17.4M -$6.23M -$4.32M -226% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-15
Q2 2020 -$13.1M -$4.78M -$3.08M -182% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-16
Q1 2020 -$10M -$4.19M -$2.27M -118% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-14
Q4 2019 -$7.77M -$2.24M +$753K +25.1% Oct 1, 2019 Dec 31, 2019 10-K 2021-03-31
Q3 2019 -$8.52M -$1.91M +$1.94M +50.4% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-16
Q2 2019 -$10.5M -$1.7M +$2.19M +56.3% Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-12
Q1 2019 -$12.7M -$1.92M +$1.94M +50.2% Jan 1, 2019 Mar 31, 2019 10-Q 2020-06-30
Q4 2018 -$14.6M -$3M +$1.69M +36% Oct 1, 2018 Dec 31, 2018 10-K 2020-05-14
Q3 2018 -$16.3M -$3.85M +$1.99M +34% Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-14
Q2 2018 -$18.3M -$3.88M +$1.33M +25.5% Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-14
Q1 2018 -$19.6M -$3.86M +$1.05M +21.3% Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-15
Q4 2017 -$20.6M -$4.68M +$1.34M +22.2% Oct 1, 2017 Dec 31, 2017 10-K 2019-03-14
Q3 2017 -$22M -$5.84M -$961K -19.7% Jul 1, 2017 Sep 30, 2017 10-Q 2018-11-14
Q2 2017 -$21M -$5.22M +$578K +9.98% Apr 1, 2017 Jun 30, 2017 10-Q 2018-08-14
Q1 2017 -$21.6M -$4.91M -$255K -5.49% Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-15
Q4 2016 -$21.3M -$6.02M -$508K -9.22% Oct 1, 2016 Dec 31, 2016 10-Q 2017-02-14
Q3 2016 -$20.8M -$4.88M -$32.6K -0.67% Jul 1, 2016 Sep 30, 2016 10-Q 2017-11-14
Q2 2016 -$20.8M -$5.79M -$419K -7.8% Apr 1, 2016 Jun 30, 2016 10-KT 2018-03-26
Q1 2016 -$20.4M -$4.65M -$255K -5.8% Jan 1, 2016 Mar 31, 2016 10-Q 2017-04-12
Q4 2015 -$20.1M -$5.51M -$2.41M -77.6% Oct 1, 2015 Dec 31, 2015 10-Q 2017-02-14
Q3 2015 -$17.7M -$4.84M -$3.76M -348% Jul 1, 2015 Sep 30, 2015 10-Q 2016-11-14
Q2 2015 -$14M -$5.38M -$4.51M -518% Apr 1, 2015 Jun 30, 2015 10-K 2016-09-28
Q1 2015 -$9.45M -$4.4M -$3.94M -858% Jan 1, 2015 Mar 31, 2015 10-Q 2016-05-13
Q4 2014 -$5.52M -$3.1M -$2.94M -1801% Oct 1, 2014 Dec 31, 2014 10-Q 2016-02-12
Q3 2014 -$2.57M -$1.08M -$902K -500% Jul 1, 2014 Sep 30, 2014 10-Q 2015-11-12
Q2 2014 -$1.67M -$870K -$729K -520% Apr 1, 2014 Jun 30, 2014 10-K 2015-09-25
Q1 2014 -$943K -$459K Jan 1, 2014 Mar 31, 2014 10-Q 2015-05-14
Q4 2013 -$163K Oct 1, 2013 Dec 31, 2013 10-Q 2015-02-12
Q3 2013 -$180K Jul 1, 2013 Sep 30, 2013 10-Q 2014-11-13
Q2 2013 -$140K May 15, 2013 Jun 30, 2013 10-K 2014-09-29
* An asterisk sign (*) next to the value indicates that the value is likely invalid.